Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
1 drug for “Bladder (Urothelial, Transitional Cell) Cancer”
Phase 3 1
- TARA-002Protara Therapeutics, Inc.Bladder (Urothelial, Transitional Cell) Cancer
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.